Psychedelic Medicine Company Approved To Study Sublingual Psilocybin For Major Depressive Disorder

  • 📰 Forbes
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 53%

Business News News

Business Business Latest News,Business Business Headlines

A psychedelic medicine company will launch a phase two clinical trial on its sublingual formulation of psilocybin, the psychedelic compound found in “magic mushrooms”, for patients with Major Depressive Disorder later this year

data from its phase three clinical trial with MDMA-assisted therapy for post-traumatic stress disorder, showing that 67% of participants who received three treatments no longer qualified for a PTSD diagnosis and 88% experienced a clinically meaningful reduction in symptoms. Other companies like MindMed, which is studying LSD for anxiety and a modified version of ibogaine to treat opioid-use disorder, have also listed on Nasdaq.

Cybin’s phase two study will be conducted in two parts at Jamaica’s University of West Indies Hospital. The first part of the clinical trial will consist of a Phase IIa study of 40 patients to identify the equivalent dose of Cybin’s sublingual psilocybin formulation compared with a 25 mg pill of psilocybin. Cybin’s sublingual film is designed for rapid absorption, a faster onset, and a shorter duration.

Cybin is starting with psilocybin, but the company is developing novel molecules based on other psychedelic compounds. The company has filed 12 provisional patent applications for novel psychedelic compounds.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

👀

For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him Blakescott64 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Psychedelic Medicine Company Approved To Study Sublingual Psilocybin For Major Depressive DisorderA psychedelic medicine company will launch a phase two clinical trial on its sublingual formulation of psilocybin, the psychedelic compound found in “magic mushrooms”, for patients with Major Depressive Disorder later this year Where do I sign? RatkoMartinovic Hmm akshaat
Source: Forbes - 🏆 394. / 53 Read more »

Study Shows People Working From Home Are Having Sex, Dating, Taking Naps And Doing Side Hustles On Company TimeA study shows people working from home are having sex, dating, taking naps and doing side hustles on company time You forgot to mention working longer hours, looking after kids who are home from school, and dealing with social isolation. Your story is a crock. Another study shows some people's employers expect them to be accessible 24/7 no matter where they are or what they're doing. Trash publication and propaganda outlet of the Plutocracy.
Source: Forbes - 🏆 394. / 53 Read more »